Skip to main content
. 2020 Sep 18;13(12):100870. doi: 10.1016/j.tranon.2020.100870

Table 1.

Patients characteristics.

Median age at sarcoma diagnosis, years [IC 95%] 48 [0–83]
Median age at locally advanced/metastatic diagnosis, years [IC 95%] 50 [5–83]
Median age at inclusion, years [IC 95%] 51.3 [6.8–84.6]
Sex:
 Female 85 (58%)
 Male 73 (42%)
Performance status:
 0 46 (29%)
 1 74 (47%)
 2 19 (12%)
 3 5 (3%)
 NA 14 (9%)
Tumor location:
 Trunk 39 (25%)
 Intra-abdominal 68 (43%)
 Limbs 51 (32%)
Genomic profile:
 Single driver genomic alteration 57 (36%)
 Complex genomic profile 101 (64%)
Median OS after metastatic diagnosis, years [IC 95%] 4.34 [3.73–5.15]